Precision BioSciences has recently revealed that iECURE, its partner, has been granted approval by the UK's Medicines and Healthcare products ...
Precision BioSciences is experiencing a decline in shares as they unveil a $40 million offering of common stock and warrants ...
Precision BioSciences has just unveiled its plans for a public offering of common stock and warrants on February 29, 2024. ...
On February 14, 2024, a trading halt will temporarily suspend all trading activities for a security or securities at various ...
On February 12, 2024, Precision Biosciences announced a groundbreaking partnership with TG Therapeutics. This collaboration involves an exclusive license for ...
